Mohamed Zeinhom Shares The Results of TACTIS Trial
Mohamed Zeinhom, Lecturer of Neurology at Kafr-Elsheikh University, shared on LinkedIn:
”It is my pleasure to share with you the results of our TACTIS trial, where we found that combining cilostazol with aspirin in large-vessel occlusion minor ischemic stroke or TIA was as effective as ticagrelor and aspirin in preventing recurrent stroke, MI, and death due to vascular events, but resulted in significantly lower rates of hemorrhagic complications.”
Read the full article here.
Article: Ticagrelor plus aspirin versus cilostazol plus aspirin in the acute-phase treatment of large-vessel minor stroke or TIA: A randomized controlled multi-center trial, the TACTIS trial
Authors: Mohamed Ismaiel, Sherihan Rezk Ahmed, Mohamed G. Zeinhom et al.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 10, 2026, 13:36Nirupama Yechoor: How Survivors of Stroke Define Spiritual Wellbeing in Recovery
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer
-
Mar 10, 2026, 12:54RishiRaj Sinha: Connecting Researchers Driving the Future of Stem Cell Science at ISSCR 2026
-
Mar 10, 2026, 12:48Kayley Pappas: Translating Cutting-Edge Science Into Better Care and Hope for Stroke Patients at Mayo Clinic